Adding Preoperative Radiotherapy Plus Cetuximab to Perioperative Chemotherapy for Resectable Esophageal Adenocarcinoma: A Single-Center Prospective Phase II Trial

BACKGROUND. Local and systemic recurrence are important sources of treatment failure following surgical resection of esophageal adenocarcinoma. We hypothesized that adding preoperative cetuximab and radiotherapy (cetux-RT) to perioperative chemotherapy would increase treatment efficacy with acceptab...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ubink, Inge, van der Sluis, Pieter, Schipper, Marguerite, Reerink, Onne, Voest, Emile, Borel-Rinkes, Inne, Wijrdeman, Harm, Vleggaar, Frank, Agterof, Marriete, Overkleeft, Esther, Siersema, Peter, van Hillegersberg, Richard, Lolkema, M.P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2014
Soggetti:
Clinical Trial Results
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3903062/
https://ncbi.nlm.nih.gov/pubmed/24335595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0254
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi